Log in

OTCMKTS:TRSSF - Terrascend Stock Price, Forecast & News

$2.04
-0.06 (-2.86 %)
(As of 12/8/2019 03:23 AM ET)
Today's Range
$2.00
Now: $2.04
$2.15
50-Day Range
$2.11
MA: $3.10
$3.83
52-Week Range
$2.00
Now: $2.04
$7.01
Volume52,798 shs
Average Volume55,646 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
TerrAscend Corp., a biopharmaceutical and wellness company, engages in the cultivation, development, and sale of medical cannabis in Canada. The company offers its cannabis products under the Knüba Naturals brand. It also provides education and support programs to physicians and patients through health care professionals. The company was incorporated in 2017 and is based in Mississauga, Canada.

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:TRSSF
CUSIPN/A
CIKN/A
Phone855-837-7295

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive TRSSF News and Ratings via Email

Sign-up to receive the latest news and ratings for TRSSF and its competitors with MarketBeat's FREE daily newsletter.


Terrascend (OTCMKTS:TRSSF) Frequently Asked Questions

What is Terrascend's stock symbol?

Terrascend trades on the OTCMKTS under the ticker symbol "TRSSF."

Has Terrascend been receiving favorable news coverage?

Media coverage about TRSSF stock has been trending somewhat positive on Sunday, InfoTrie Sentiment Analysis reports. The research group rates the sentiment of media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Terrascend earned a media sentiment score of 2.0 on InfoTrie's scale. They also gave news stories about the company a news buzz of 8.0 out of 10, indicating that recent media coverage is very likely to have an effect on the stock's share price in the near future. View News Stories for Terrascend.

Who are some of Terrascend's key competitors?

What other stocks do shareholders of Terrascend own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Terrascend investors own include Aphria (APHA), Aurora Cannabis (ACB), Canopy Growth (CGC), CV Sciences (CVSI), Cronos Group (CRON), OrganiGram (OGI), Curaleaf (CURLF), Charlotte's Web (CWBHF), KushCo (KSHB) and Medmen Enterprises (MMNFF).

Who are Terrascend's key executives?

Terrascend's management team includes the folowing people:
  • Dr. Michael Nashat, Founder, CEO, COO & Director (Age 35)
  • Mr. Matthew J. Johnson, Pres
  • Mr. Adam Kozak, Chief Financial Officer
  • Mr. Alex Correia, VP of Corp. Affairs & Communications
  • Ms. Dawn Vanek-Mithra, Director of Marketing

How do I buy shares of Terrascend?

Shares of TRSSF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Terrascend's stock price today?

One share of TRSSF stock can currently be purchased for approximately $2.04.

What is Terrascend's official website?

The official website for Terrascend is http://www.terrascend.com/.

How can I contact Terrascend?

The company can be reached via phone at 855-837-7295.


MarketBeat Community Rating for Terrascend (OTCMKTS TRSSF)

Community Ranking:  3.9 out of 5 (star star star)
Outperform Votes:  22 (Vote Outperform)
Underperform Votes:  6 (Vote Underperform)
Total Votes:  28
MarketBeat's community ratings are surveys of what our community members think about Terrascend and other stocks. Vote "Outperform" if you believe TRSSF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TRSSF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/8/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel